True but the NPAT figure of 7,116,772 there is also 600,593 of acquisition expenses and approx 2.1 million in head office expenses, both these amounts are said to be non operational which I would take as non recurring. The head office expenses may be some what recurring but even at 50% rate the other deferred consideration is almost all offset. There are no tricks being pulled here as far as I can see.
- Forums
- ASX - By Stock
- Ann: PS&C Ltd FY15 Investor Presentation
True but the NPAT figure of 7,116,772 there is also 600,593 of...
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ASV (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.2¢ |
Change
-0.001(4.35%) |
Mkt cap ! $16.19M |
Open | High | Low | Value | Volume |
2.2¢ | 2.2¢ | 2.0¢ | $26.57K | 1.228M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 175000 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.6¢ | 93000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 175000 | 0.021 |
3 | 322511 | 0.020 |
1 | 2631 | 0.019 |
1 | 1000000 | 0.015 |
1 | 20000 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.026 | 93000 | 1 |
0.027 | 63400 | 1 |
0.029 | 88714 | 1 |
0.030 | 533300 | 2 |
0.031 | 2200000 | 2 |
Last trade - 14.51pm 10/10/2024 (20 minute delay) ? |
Featured News
ASV (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online